- Home
- PACB vs CYRX Comparison
PACB vs CYRX Comparison
Compare PACB & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- CYRX
- Stock Information
- Founded
- PACB 2000
- CYRX 1999
- Country
- PACB United States
- CYRX United States
- Employees
- PACB N/A
- CYRX N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- PACB Industrials
- CYRX Health Care
- Exchange
- PACB Nasdaq
- CYRX Nasdaq
- Market Cap
- PACB 462.1M
- CYRX 438.7M
- IPO Year
- PACB 2010
- CYRX N/A
- Fundamental
- Price
- PACB $1.34
- CYRX $8.72
- Analyst Decision
- PACB Buy
- CYRX Strong Buy
- Analyst Count
- PACB 7
- CYRX 10
- Target Price
- PACB $1.90
- CYRX $11.70
- AVG Volume (30 Days)
- PACB 7.2M
- CYRX 1.1M
- Earning Date
- PACB 08-07-2025
- CYRX 08-05-2025
- Dividend Yield
- PACB N/A
- CYRX N/A
- EPS Growth
- PACB N/A
- CYRX N/A
- EPS
- PACB N/A
- CYRX 1.35
- Revenue
- PACB $156,110,000.00
- CYRX $237,879,000.00
- Revenue This Year
- PACB $5.26
- CYRX N/A
- Revenue Next Year
- PACB $16.13
- CYRX $9.08
- P/E Ratio
- PACB N/A
- CYRX $6.37
- Revenue Growth
- PACB N/A
- CYRX 24.93
- 52 Week Low
- PACB $0.85
- CYRX $4.58
- 52 Week High
- PACB $2.72
- CYRX $9.48
- Technical
- Relative Strength Index (RSI)
- PACB 50.23
- CYRX 59.17
- Support Level
- PACB $1.21
- CYRX $8.66
- Resistance Level
- PACB $1.40
- CYRX $9.05
- Average True Range (ATR)
- PACB 0.09
- CYRX 0.49
- MACD
- PACB 0.01
- CYRX -0.00
- Stochastic Oscillator
- PACB 73.81
- CYRX 76.92
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.